Literature DB >> 15332366

[Cardiac failure in Chilean hospitals: results of the National Registry of Heart Failure, ICARO].

Pablo Castro1, José Luis Vukasovic, Eduardo Garcés, Luis Sepúlveda, Marcela Ferrada, Sergio Alvarado.   

Abstract

BACKGROUND: Heart failure (HF) is a major public health problem. In Chile hospitalized patients due to HF have not been characterized. AIM: To evaluate clinical profile and outcome of patients hospitalized for heart failure in Chilean hospitals. PATIENTS AND METHODS: Prospective registry of 14 centers. Patients hospitalized for HF in functional class III and IV were included. Epidemiological and clinical data, functional class, type of presentation, decompensation cause, electrocardiogram, echocardiogram, treatment and evolution were registered.
RESULTS: Three hundred seventy two patients aged 69 +/- 13 years old, 59% men, were assessed. The main etiologies of HF were ischemic in 31.6%, hypertensive in 35.2%, valvular in 14.9% and idiopathic in 7.4%. There was a history of hypertension 69%, diabetes in 35%, myocardial infarction in 22%, atrial fibrillation (AF) in 28%. The presentation form of HF was chronic decompensated in 86%, acute in 12%, refractory in 2%. The causes of decompensation were non compliance with diet or medical prescriptions in 28%, infections in 22% and AF 17%. ECG showed AF in 36% and left bundle branch block in 16%. Echocardiography was performed in 52% of the patients, 69% had left ventricular ejection fraction <40%. On admission, 39% received angiotensin converting enzyme (ACE) inhibitors, 15% beta-blocker, 25% digoxin, 16% spironolactone and 53% furosemide. The mean hospital stay was 111 +/- 10 days and mortality was 4.5%.
CONCLUSIONS: The elderly is the age group most commonly admitted to hospital due to HF. The main etiologies were ischemic and hypertensive. The main causes for decompensations were noncompliance with diet or medical prescriptions and infections. A significant proportion had a relatively well preserved ventricular systolic function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15332366     DOI: 10.4067/s0034-98872004000600001

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  4 in total

1.  Study Protocol for the Peruvian Registry of Advanced Heart Failure (REPICAV).

Authors:  Manuel Chacón-Diaz; Rocío Laymito Quispe; Akram Hernández-Vásquez; Rodrigo Vargas-Fernández
Journal:  Front Cardiovasc Med       Date:  2022-05-31

Review 2.  Worldwide risk factors for heart failure: a systematic review and pooled analysis.

Authors:  Shahab Khatibzadeh; Farshad Farzadfar; John Oliver; Majid Ezzati; Andrew Moran
Journal:  Int J Cardiol       Date:  2012-11-30       Impact factor: 4.164

3.  Predictors and outcomes of infection-related hospital admissions of heart failure patients.

Authors:  Danny Alon; Gideon Y Stein; Roman Korenfeld; Shmuel Fuchs
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

Review 4.  Heart failure care in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Thomas Callender; Mark Woodward; Gregory Roth; Farshad Farzadfar; Jean-Christophe Lemarie; Stéphanie Gicquel; John Atherton; Shadi Rahimzadeh; Mehdi Ghaziani; Maaz Shaikh; Derrick Bennett; Anushka Patel; Carolyn S P Lam; Karen Sliwa; Antonio Barretto; Bambang Budi Siswanto; Alejandro Diaz; Daniel Herpin; Henry Krum; Thomas Eliasz; Anna Forbes; Alastair Kiszely; Rajit Khosla; Tatjana Petrinic; Devarsetty Praveen; Roohi Shrivastava; Du Xin; Stephen MacMahon; John McMurray; Kazem Rahimi
Journal:  PLoS Med       Date:  2014-08-12       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.